Glaxo Slapped With Avandia Personal Injury Suit

Law360, New York (June 1, 2007, 12:00 AM EDT) -- On the heels of warnings from federal regulators over the safety of its diabetes drug Avandia, GlaxoSmithKline is facing what may be the first of many product liability lawsuits over claims that it failed to disclose that the popular drug may significantly boost the risk of heart attack and heart-related death.

The proposed class action, filed Thursday in the U.S. District Court for the District of Puerto Rico, was brought by Celenio Cruz-Santana on behalf of himself and all similarly situated patients who took Avandia or...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.